ARTICLE | Company News
Advanced Cancer Therapeutics, University of Louisville deal
March 31, 2008 7:00 AM UTC
Advanced Cancer Therapeutics received an exclusive, worldwide license from the university to develop and commercialize 4-IPP and related compounds. The small molecule inhibitor of macrophage migrati...